SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-19-022739
Filing Date
2019-11-12
Accepted
2019-11-12 08:01:40
Documents
90
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0919_immucellcorporation.htm 10-Q 610931
2 CERTIFICATION f10q0919ex31_immucellcorp.htm EX-31 8453
3 CERTIFICATION f10q0919ex32_immucellcorp.htm EX-32 4443
  Complete submission text file 0001213900-19-022739.txt   4676479

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE FILE iccc-20190930.xml EX-101.INS 865379
5 XBRL SCHEMA FILE iccc-20190930.xsd EX-101.SCH 58021
6 XBRL CALCULATION FILE iccc-20190930_cal.xml EX-101.CAL 70381
7 XBRL DEFINITION FILE iccc-20190930_def.xml EX-101.DEF 186715
8 XBRL LABEL FILE iccc-20190930_lab.xml EX-101.LAB 422783
9 XBRL PRESENTATION FILE iccc-20190930_pre.xml EX-101.PRE 329834
Mailing Address 56 EVERGREEN DRIVE PORTLAND ME 04103
Business Address 56 EVERGREEN DR PORTLAND ME 04103 2078782770
IMMUCELL CORP /DE/ (Filer) CIK: 0000811641 (see all company filings)

IRS No.: 010382980 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-12934 | Film No.: 191206228
SIC: 2835 In Vitro & In Vivo Diagnostic Substances